Jennifer Danielson1, Dayl Eccles1, Abigail Kwasnik2, Karen Craddick3, Andrew K Heinz4, Arthur F Harralson5. 1. School of Pharmacy, University of Washington, Seattle, Washington. 2. St. Joseph Hospital Franciscan Health-System, Tacoma, Washington. 3. University of Washington Medical Center, Seattle, Washington. 4. Kirk's Pharmacy, Eastonville, Washington. 5. Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, Virginia.
Abstract
OBJECTIVE: To assess financial, personnel, and curricular characteristics of US pharmacy practice experiential education programs and follow-up on results of a similar survey conducted in 2001. METHODS: Experiential education directors at 118 accredited US pharmacy colleges and schools were invited to participate in a blinded, Web-based survey in 2011. Aggregate responses were analyzed using descriptive statistics and combined with data obtained from the American Association of Colleges of Pharmacy to assess program demographics, faculty and administrative organizational structure, and financial support. RESULTS: The number of advanced pharmacy practice experience (APPE) sites had increased by 24% for medium, 50% for large, and 55% for very large colleges and schools. Introductory pharmacy practice experience (IPPE) sites outnumbered APPEs twofold. The average experiential education team included an assistant/associate dean (0.4 full-time equivalent [FTE]), a director (1.0 FTE), assistant/associate director (0.5 FTE), coordinator (0.9 FTE), and multiple administrative assistants (1.3 FTE). Most faculty members (63%-75%) were nontenure track and most coordinators (66%) were staff members. Estimated costs to operate an experiential education program represented a small percentage of the overall expense budget of pharmacy colleges and schools. CONCLUSION: To match enrollment growth, pharmacy practice experiential education administrators have expanded their teams, reorganized responsibilities, and found methods to improve cost efficiency. These benchmarks will assist experiential education administrators to plan strategically for future changes.
OBJECTIVE: To assess financial, personnel, and curricular characteristics of US pharmacy practice experiential education programs and follow-up on results of a similar survey conducted in 2001. METHODS: Experiential education directors at 118 accredited US pharmacy colleges and schools were invited to participate in a blinded, Web-based survey in 2011. Aggregate responses were analyzed using descriptive statistics and combined with data obtained from the American Association of Colleges of Pharmacy to assess program demographics, faculty and administrative organizational structure, and financial support. RESULTS: The number of advanced pharmacy practice experience (APPE) sites had increased by 24% for medium, 50% for large, and 55% for very large colleges and schools. Introductory pharmacy practice experience (IPPE) sites outnumbered APPEs twofold. The average experiential education team included an assistant/associate dean (0.4 full-time equivalent [FTE]), a director (1.0 FTE), assistant/associate director (0.5 FTE), coordinator (0.9 FTE), and multiple administrative assistants (1.3 FTE). Most faculty members (63%-75%) were nontenure track and most coordinators (66%) were staff members. Estimated costs to operate an experiential education program represented a small percentage of the overall expense budget of pharmacy colleges and schools. CONCLUSION: To match enrollment growth, pharmacy practice experiential education administrators have expanded their teams, reorganized responsibilities, and found methods to improve cost efficiency. These benchmarks will assist experiential education administrators to plan strategically for future changes.
Authors: Samuel F Stolpe; Alex J Adams; Lynette R Bradley-Baker; Anne L Burns; James A Owen Journal: Am J Pharm Educ Date: 2011-10-10 Impact factor: 2.047
Authors: Jennifer Danielson; Juancho Ramirez; Janelle Krueger; Lindsay Christensen; Cara A Harshberger; Luke Rice; Gayle A Hudgins; Stanley Weber Journal: Am J Pharm Educ Date: 2011-12-15 Impact factor: 2.047
Authors: Maryann Z Skrabal; Rhonda M Jones; Ruth E Nemire; Cynthia J Boyle; Mitra Assemi; Abby A Kahaleh; Denise A Soltis; Rondall E Allen; Philip M Hritcko; Teresa A O'Sullivan; Christopher J Destache Journal: Am J Pharm Educ Date: 2008-10-15 Impact factor: 2.047
Authors: Douglas J Scheckelhoff; Colleen G Bush; Arlene A Flynn; George E MacKinnon; Charles E Myers; Abby A Kahaleh; Katherine K Knapp; Joy L Meier; Terrence L Schwinghammer; Steven L Sheaffer; Brent J Thompson; Charles F McCluskey Journal: Am J Health Syst Pharm Date: 2008-11-01 Impact factor: 2.637
Authors: P David Brackett; Debbie C Byrd; Lori J Duke; James W Fetterman; Whitney L Unterwagner; April G Staton; Mindi S Miller; Melody C Sheffield; William K Kennedy; Charles H McDuffie; T Lynn Stevenson; Paula A Thompson; Elizabeth S McCullough Journal: Am J Pharm Educ Date: 2009-08-28 Impact factor: 2.047
Authors: Cathy L Worrall; Daniel S Aistrope; Elizabeth A Cardello; Katrin S Fulginiti; Ronald P Jordan; Steven J Martin; Kyle McGrath; Sharon K Park; Brian Shepler; Karen Whalen; Lynette R Bradley-Baker Journal: Am J Pharm Educ Date: 2016-11-25 Impact factor: 2.047
Authors: Teresa A O'Sullivan; Craig D Cox; Patricia Darbishire; Melissa M Dinkins; Erin L Johanson; Andrea Joseph; Susan Vos Journal: Am J Pharm Educ Date: 2020-02 Impact factor: 2.047